mkm109
Regular
I have used the system before for other shares and it sometimes works and sometimes fails
BRN Discussion Ongoing
- Thread starter TechGirl
- Start date
Bravo
If ARM was an arm, BRN would be its biceps💪!
Dhm
Regular
I enjoyed catching up with quite a few of the 1000 eyes this morning. And got to look at the Akida 1000 up close. Tony Dawe said that future Akida chips will be a bit smaller than this one, and this fits on a fingernail.
The senior management were quite slick, but if I was to be a little picky, Sean read everything he said in the prepared part of the morning. Afterwards in the Q and A he was impressive
The chairman Antonio Viana was very impressive as well. I’ve arranged a game of golf when Sean and Antonio next come down (perhaps they were paying lip service to me) but I can always hope!
The savaging of the SP today has no logical reason, and as Antonio said, “the share price will do what the share price will do”.
I am firmly confident that we are backing the right horse with Brainchip. Hopefully we will demonstrate soon that we had all the horses in the race!
@Fact Finder we missed you today, I even had a birthday present for you. Or were you there in disguise….. I thought I may have seen Blind Freddie in the room.
The senior management were quite slick, but if I was to be a little picky, Sean read everything he said in the prepared part of the morning. Afterwards in the Q and A he was impressive
The chairman Antonio Viana was very impressive as well. I’ve arranged a game of golf when Sean and Antonio next come down (perhaps they were paying lip service to me) but I can always hope!
The savaging of the SP today has no logical reason, and as Antonio said, “the share price will do what the share price will do”.
I am firmly confident that we are backing the right horse with Brainchip. Hopefully we will demonstrate soon that we had all the horses in the race!
@Fact Finder we missed you today, I even had a birthday present for you. Or were you there in disguise….. I thought I may have seen Blind Freddie in the room.
Rise from the ashes
Regular
Truly amazing what has evolved in a number of industries lately.
SiDEvans
Regular
At one point Sean made a very clear point about the identity of the company when he said something to the effect of … “we are an IP company, not a chip company.”
He actually repeated that a few times in the same response to a question I believe was about the R&D department. No matter the actual question, I found this very interesting as I had never heard them take this position so strongly before.
As they have said in the past this form of revenue is very high margin so bring it on!
He actually repeated that a few times in the same response to a question I believe was about the R&D department. No matter the actual question, I found this very interesting as I had never heard them take this position so strongly before.
As they have said in the past this form of revenue is very high margin so bring it on!
Dhm
Regular
Oh, the other thing, I asked Sean and Antony about last November's US Congress decision to equip all new cars with driver monitors to detect intoxication and distraction, and what opportunity this is for Brainchip, and Sean replied that they are certainly aware of this, but sadly nothing more. I personally think that Brainchip would be all over that opportunity. Apparently this is law in Europe too.
Also a question about the timing for the FDA trials with Nanose being May 31 and how that may be going, and,......"we can't really comment on that". Course you can.....just a little hint, please!!
Also a question about the timing for the FDA trials with Nanose being May 31 and how that may be going, and,......"we can't really comment on that". Course you can.....just a little hint, please!!
Azzluvstrades
Member
A tidy 4million shares traded after hours today!
Hi Sid,
If someone wants the chip, we have the likes of MegaChips to sort that out. No point in us competing with the pros in our team.
Are you ok?I've worked it out! The Finder of Facts found something untoward at the AGM and sold all of his shares (hence the SP drop) and he's now running for the hills (hence the 'sound of crickets'). Will we ever hear from FF again?.......
Xhosa12345
Regular
i think hes still typing just quietly....
Just having a bit of fun
Referenced previously @Rise from the ashes
It looks like Hossam Haick will be commenting though. Albeit at the end of September when his new book is released:
Volatile Biomarkers for Human Health – “From Nature to Artificial Senses”
The brief:
Volatile biomarkers play a significant signalling role in communication between biological cells living as individual entities or as mini-societies that sense, respond and adapt to changes in their environment. In this process, volatile biomarkers can leak into the blood, from which they can be secreted into most body fluids (blood, breath, skin, urine, saliva, feces, etc.), from which sensing devices can capture and interpret their chemical fingerprint to reflect any association with health disorders in a fast, easy, and minimally non-invasive manner.
This book introduces the concept of biomarkers within the body in terms of basic and translational sciences. It starts with a comprehensive review of the expression and mechanistic pathways involving volatile biomarkers at single cell and (micro)organism levels, cell-to-cell and cell-to-organism communications, and their secretion into body fluids. It discusses several ways for discovering and detecting the secreted biomarkers using mass spectrometry and other spectroscopic techniques. This is followed by an appraisal and translation of the accumulating knowledge from the laboratory to the Point-of-Care phase, using selective sensors as well as desktop and wearable artificial sensing devices, e.g., electronic noses and electronic skins, in conjugation with AI-assisted data processing and healthcare decision-making in diagnostics. The book offers an outlook into the challenges in the continuing development of volatile biomarkers and their wider availability to healthcare, which can be substantially improved. It should appeal to research groups in universities, start-up and large-scale industries associated in all aspects of biomedicine.
Similar threads
